Says poised for transformational value creation. Says momentum remains robust. Says clear opportunity for value creation upside in microbiology. Says tariff landscape has improved. Says tariff impact outlook is unchanged. Says Xevo TQ XR has exceed all expectations. Comments taken from Q2 earnings conference call.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WAT: